Structural Modification and Pharmacological Evaluation of Substituted Quinoline-5,8-diones as Potent NSD2 Inhibitors
Hairong Tang(Shanghai Jiao Tong University), Ao Zhang(Sun Yat-sen University Cancer Center), Aisong Yu(Chinese Academy of Sciences), Huaqian Ding(Shanghai Jiao Tong University), Hong Yang(Chonnam National University), Zilan Song(Chinese Academy of Sciences), Xun Huang(Chinese Academy of Sciences), Xing Li(Central South University), Xiaoyu Chen(Anhui Medical University), Meiyu Geng(Shanghai Institute of Materia Medica), Qiongyu Shi(Chinese Academy of Sciences)
Cited by 23
Related Papers
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
|Cell Research|2019|1.1k
Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information
|Nucleic Acids Research|2015|285
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs
|Briefings in Bioinformatics|2018|158